Renflexis 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FHF40
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $44,302
Award facts
- Contract value 100% obligated
- $44,302.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $44,302.32 delivery order to AmerisourceBergen Drug Corp for Renflexis 100 mg vials, with a completion date of June 3, 2025. This competitively awarded, non-set-aside contract is priced on a firm fixed-price basis and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Renflexis is a biosimilar to Remicade used in treating autoimmune conditions, representing the pharmaceutical distributor's continued role in supplying specialized medical products to federal healthcare systems.
This delivery order operates under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC, designated SPE2DX, serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs worldwide. AmerisourceBergen's demonstrated capability to meet federal procurement requirements through open competition and its established relationship with DLA positions it as a critical vendor supporting Defense Health Agency operations and other federal healthcare initiatives.
Quick answers
Who was awarded contract SPE2DB25FHF40?
SPE2DB25FHF40 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FHF40 worth?
The government has obligated $44,302 on SPE2DB25FHF40.
Is contract SPE2DB25FHF40 an order under another contract?
Yes. SPE2DB25FHF40 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FHF40 competed?
The extent of competition for SPE2DB25FHF40 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award